Enliven Therapeutics, Inc. ELVN
$42.96
▲ +14.30% 24H
About
Enliven Therapeutics Inc. is a biotechnology company dedicated to the development of novel therapeutic solutions targeting specific diseases. The primary focus of the company lies in advancing the field of precision medicine, which aims to tailor medical treatment to the individual characteristics of each patient, enha…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees61
TickerELVN
Statistics
Market Cap$2.62B
Revenue (TTM)$0
Net Income-$103.7M
Net Margin—
EPS$-1.83
P/E-22.04
P/S—
P/B5.42
EV/EBITDA-17.36
ROE-26.6%
Dividend Yield—
Price$42.96
Data: Twelve Data · Revenue = mcap / P/S